ASLAN Pharmaceuticals Limited
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$44,219,604 and profit margin reached -368%. Total operating expenses were $55,387,099.

Profit Margin

ASLAN Pharmaceuticals Limited (NASDAQ:ASLN): Profit margin
2014 0 -7.36M
2015 0 -13.32M
2016 11.48M -9.00M -78.37%
2017 0 -40.71M
2018 0 -42.18M
2019 3M -47.06M -1568.85%
2020 0 -17.90M
2021 0 -34.70M
2022 0 -51.38M
2023 12M -44.21M -368.5%

ASLN Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
12M0003M0011.48M00
Cost of revenue
348.49K331.75K282.22K297.75K407.25K0209.08K124.37K52.08K0
Gross profit
11.65M-331.75K-282.22K-297.75K2.59M0-209.08K11.36M-52.08K0
Operating exp.
Research and development
42.49M38.00M22.02M9.31M16.58M31.83M30.61M13.09M6.22M4.49M
Selling and marketing
-348.49K000000000
Total operating expenses
55.38M47.88M33.84M16.48M48.17M42.34M39.94M20.02M12.83M7.31M
Operating income
-43.73M-47.88M-33.84M-16.48M-45.57M-42.34M-39.94M-8.65M-12.83M-7.31M
Other income (expenses), net
-342.75K-3.40M2.25M-487.99K-1.07M176.91K-767.72K-347.67K-1.13M-49.51K
Income before tax
-44.07M-51.28M-31.59M-16.97M-46.65M-42.17M-40.71M-9.00M-13.32M-7.36M
Income tax expense
132.66K99.22K3.11M934.92K408.00K14.43K-342.45K173.83K500.02K245.88K
Net income
-44.21M-51.38M-34.70M-17.90M-47.06M-42.18M-40.71M-9.00M-13.32M-7.36M
Earnings per share
Basic EPS
-2.69-3.68-2.66-2.33-7.25-7.04-8.18-1.73-6.05-28.81
Diluted EPS
-2.69-3.68-2.66-2.33-7.25-7.04-7.82-1.73-6.05-28.81
Data sourceData sourceData sourceData sourceData sourceData source